These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5923831)

  • 41. [On the analgesia-shortening effect of sulfonamides].
    GORES E
    Acta Biol Med Ger; 1963; 10():679-80. PubMed ID: 13949260
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of some adrenal steroids on hexobarbital and hydroxydione anaesthesia.
    Kostowski W; Nowacka M
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):362-5. PubMed ID: 4393843
    [No Abstract]   [Full Text] [Related]  

  • 43. [Some pharmacodynamical properties of the glucoside derivative of p-aminoacetophenone].
    Putowa A; Palka W; Sykulski J; Wójcicki J
    Acta Pol Pharm; 1967; 24(4):431-6. PubMed ID: 6081805
    [No Abstract]   [Full Text] [Related]  

  • 44. The central nervous effects of bis-(4-aminophenyl)-alkyl derivatives.
    Leszkovszky GP; Tardos L; Sebestyén G; Takács K
    Acta Physiol Acad Sci Hung; 1968; 34(4):333-43. PubMed ID: 5712949
    [No Abstract]   [Full Text] [Related]  

  • 45. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of the optical isomers of some aminoalkyl esters of disubstituted acetic and glycolic acids on hypnotic effects of hexenal and chloral hydrate in white mice].
    Zatsepin EP
    Farmakol Toksikol; 1965; 28(2):144-7. PubMed ID: 5849191
    [No Abstract]   [Full Text] [Related]  

  • 47. Benzothiazole incorporated barbituric acid derivatives: synthesis and anticonvulsant screening.
    Siddiqui N; Ahsan W
    Arch Pharm (Weinheim); 2009 Aug; 342(8):462-8. PubMed ID: 19565603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in a hexobarbital anaesthesia threshold in rats induced by repeated long-term treatment with barbital or ethanol.
    Wahlström G
    Psychopharmacologia; 1971; 19(4):366-80. PubMed ID: 5105729
    [No Abstract]   [Full Text] [Related]  

  • 49. Ipronal analogues. Synthesis, chemical and pharmacologic properties of 5-allyl-5-(beta-hydroxypropyl)-2-thio- and-2-iminobarbituric acids.
    Konieczny M; Teodorczyk J; Wagner E
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):915-31. PubMed ID: 5168997
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cardiazol therapy in acute barbituric acid poisoning].
    BOCKEL P
    Ther Ggw; 1952 Nov; 91(11):422-3. PubMed ID: 13029086
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains.
    Chmielewska B
    Pharmazie; 1984 Apr; 39(4):259-62. PubMed ID: 6204346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacologic studies of a prolonged action neuroleptic: fluphenazine enanthate].
    Boissier JR; Simon P; Lwoff JM
    Med Pharmacol Exp Int J Exp Med; 1966; 14(5):435-42. PubMed ID: 6012744
    [No Abstract]   [Full Text] [Related]  

  • 53. Augmentation of chloral hydrate induced sleep by centrally acting antihypertensive agents.
    Schuler ME; Roszkowski AP
    Proc West Pharmacol Soc; 1982; 25():347-8. PubMed ID: 7122519
    [No Abstract]   [Full Text] [Related]  

  • 54. [Influencing of the subnarcotic and cholinergically potentiated action of barbital through antiparkinson drugs in mice].
    Oelszner W; Westermann KH; Eger J
    Acta Biol Med Ger; 1971; 27(5):993-9. PubMed ID: 5148782
    [No Abstract]   [Full Text] [Related]  

  • 55. [Preliminary pharmacological studies on the central action of phenyl- and piperidinemethyl derivatives of benzoxazolone-2].
    Kolasa K; Rajtar G; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():73-81. PubMed ID: 6892098
    [No Abstract]   [Full Text] [Related]  

  • 56. [Optical purity of chiral hexobarbital and 1-methyl-5-propyl-5-phenyl-e-phenyl-barbituric acid. 17. Barbituric acid derivatives].
    Knabe J; Gradmann V
    Arch Pharm (Weinheim); 1973 Apr; 306(4):306-9. PubMed ID: 4716979
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential effects of chloral hydrate- and ketamine/xylazine-induced anesthesia by the s.c. route.
    Rodrigues SF; de Oliveira MA; Martins JO; Sannomiya P; de Cássia Tostes R; Nigro D; Carvalho MH; Fortes ZB
    Life Sci; 2006 Sep; 79(17):1630-7. PubMed ID: 16828118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The metabolic fate of 5-(1-cyclohexen-1-yl)-1, 5-dimethyl barbituric acid (hexobarbital, evipal) and of 5-(1-cyclohexen-1-yl)-5-methyl barbituric acid ("nor-evipal").
    BUSH MT; BUTLER TC; DICKISON HL
    J Pharmacol Exp Ther; 1953 May; 108(1):104-11. PubMed ID: 13053428
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuropharmacologic evaluation of 2-phenylimidazo-[1,2-a] pyrimidine hydrobromide (U-13,376B), an unusual strychnine antagonist.
    Collins RJ; Tang AH; Keasling HH
    J Pharmacol Exp Ther; 1967 Dec; 158(3):428-36. PubMed ID: 6073226
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis and pharmacologic properties of guanylhydrazones of barbituric acid derivatives.
    Konieczny M; Teodorczyk J; Bierowska D; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):385-98. PubMed ID: 5055686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.